Skip to main content

Advertisement

SpringerLink
Log in

Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

The aim of this study was to find the correlation between serum p53 and carcinoma of the bladder and to investigate whether serum p53 protein can be used as a tumor marker for p53 gene alteration. The study included patients with carcinoma of the bladder and controls. Serum p53 protein estimation was done with an ELISA kit. There were 23 patients with superficial and 17 with invasive carcinoma. The median serum p53 was 31.5 U/ml in superficial and 41 U/ml in invasive cancer. This was significantly higher than the mean value (16.4 U/ml) of controls. Serum p53 rises in patients with carcinoma of the bladder and correlates with the grade of the disease .It can therefore be used as a tumor marker for bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Brandau S, Bohle A (2001) Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 39: 491

    Article  CAS  PubMed  Google Scholar 

  2. Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K (2002) TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Int J Oncol 20: 107

    CAS  PubMed  Google Scholar 

  3. Krajewska B, Lutz W, Pilacik B (1998) Determination of blood serum oncoprotein NEU and antioncoprotein p53—molecular biomarkers in various types of occupational exposure. Int J Occup Med Environ Health 11: 343

    CAS  PubMed  Google Scholar 

  4. Schmitz-Drager BJ, Goebell PJ, Ebert T, Fradet Y (2000) P53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? Eur Urol 38: 691

    Article  CAS  PubMed  Google Scholar 

  5. Finlay CA, Hinds PW, Tan TH (1988) Activating mutations for the transformation by p53 produce a gene product that forms an hsc-p53 complex with an altered half life. Mol Cell Biol 8: 531

    CAS  PubMed  Google Scholar 

  6. Fontanini G, Fiore L, Bigini D, Vignati S, Calvo S, Mussi A, Lucchi M, Anggeletti CA, Merlo GR, Basolo F (1994) Levels of p53 antigen in the serum of non small cell lung cancer patients correlate with positive p53 immunohistochemistry on tumor sections, tumor necrosis and nodal involvement. Int J Oncol 5: 553

    Google Scholar 

  7. Chow V, Yuen APW, Lam KY, Ho WK, Wei WI (2001) Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma. Head Neck 23: 286

    Article  CAS  PubMed  Google Scholar 

  8. Luo JC, Neugut AI, Garbowski G, Forde KA, Treat M, Smith S, Carney WP, Brandt-Rauf PW (1995) Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon. Cancer Lett 91: 235

    Article  CAS  PubMed  Google Scholar 

  9. Suwa H, Ohshio G, Okada N, Wang Z, Fukumoto M, Imamura T, Imamura M (1997) Clinical significance of serum p53 antigen in patients with pancreatic carcinomas. Gut 40: 647

    CAS  PubMed  Google Scholar 

  10. Friedrich MG, Riethdorf S, Erbersdobler A, Tiemer C, Schwaibold H, Solter JK, Huland E, Riethdorf L, Conrad S, Hammerer PG, Huland H (2001) Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 39: 159

    Article  CAS  PubMed  Google Scholar 

  11. Lipponen PK (1993) Overexpression of p53 nuclear oncoproteins in transitional cell bladder cancer and its prognostic value. Int J Cancer 53: 365

    CAS  PubMed  Google Scholar 

  12. Esrig D, Elmajian D, Groshen S, Freman JA, Stein JP, Chen SC, Nichols PW, Skinner DJ, Jones PA, Cote RJ (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Eng J Med 331: 1259

    Article  CAS  Google Scholar 

  13. Jahnsons S, Risberg B, KarlssonMG, Westman G, Bergstorm R, Pedersen J (1995) p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. Eur Urol 28: 135

    PubMed  Google Scholar 

  14. Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C (2002) Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res 8: 171

    CAS  PubMed  Google Scholar 

  15. Schmitz-Drager BJ, Goebell PJ, Ebert T, Fradet Y (2000) p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? Eur Urol 38: 691

    Article  CAS  PubMed  Google Scholar 

  16. Morita T, Tachikawa N, Kumamaru T, Nukui A, Ikeda H, Suzuki K, Tokue A (2000) Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder. Cancer patients. Eur Urol 37: 79

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221 005 India

    Vibhav Malviya, Harbans Singh, U. S. Dwivedi & P. B. Singh

  2. Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221 005 India

      Usha

Authors
  1. Vibhav Malviya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harbans Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. S. Dwivedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4.   Usha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. B. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. B. Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malviya, V., Singh, H., Dwivedi, U.S. et al. Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?. Urol Res 32, 391–394 (2004). https://doi.org/10.1007/s00240-004-0415-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-004-0415-9

Keywords

Search

Navigation